Your browser doesn't support javascript.
loading
A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2.
Sur, P; Nandi, N; Ghosh, P; Ghosh, N C.
Afiliación
  • Sur P; Department of Pharmacology and Experimental Therapeutics, Indian Institute of Chemical Biology, Jadavpur University, Calcutta. iichbio@sias101.vsnl.net.in
Neoplasma ; 47(2): 114-7, 2000.
Article en En | MEDLINE | ID: mdl-10985477
Lipopolysaccharide fraction isolated from Ehrlich ascites carcinoma (E-LPS) was investigated as an antitumor agent against human leukemia cell ML-2. Marked cell growth inhibition was observed with ML-2 cell accompanied by inhibition of DNA synthesis and perturbation of cell cycle. Induction of differentiation in treated ML-2 cells was observed as indicated by morphological maturation, NBT reducing activity and indirect immunofluorescence.
Asunto(s)
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Tumorales Cultivadas / Carcinoma de Ehrlich / Leucemia Mieloide / Lipopolisacáridos / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Neoplasma Año: 2000 Tipo del documento: Article Pais de publicación: Eslovaquia
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Tumorales Cultivadas / Carcinoma de Ehrlich / Leucemia Mieloide / Lipopolisacáridos / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Neoplasma Año: 2000 Tipo del documento: Article Pais de publicación: Eslovaquia